Table 2.

HRs of total cancer, and cancer of the lung and prostate, by categories of thyrotropin, with follow-up starting 2 y after baseline

Thyrotropin (mU/L)Persons (n)Cancers (n)HR (95% CI)
Total cancer
    <0.50648671.52 (1.18-1.95)
    0.50-1.412,0508061.0 (Reference)
    1.5-2.410,5817641.04 (0.94-1.15)
    2.5-3.53,4832580.99 (0.86-1.14)
    >3.52,0741641.01 (0.86-1.20)
Lung cancer
    <0.50648102.91 (1.49-5.70)
    0.50-1.412,050621.0 (Reference)
    1.5-2.410,581481.00 (0.68-1.46)
    2.5-3.53,483231.60 (0.99-2.61)
    >3.52,07481.03 (0.49-2.17)
Prostate cancer
    <0.50160102.60 (1.36-4.99)
    0.50-1.44,2041071.0 (Reference)
    1.5-2.43,6271011.00 (0.76-1.31)
    2.5-3.51,069330.91 (0.61-1.35)
    >3.5530190.95 (0.58-1.56)
  • NOTE: HRs adjusted for age, sex, and smoking status.